Cardinal Health's DEI Employment Practices: What the Company's Own Documents Show — and What They Mean for Employees

Published August 27, 2026 · Last updated August 27, 2026 · By Fett Law — Michigan Employment Discrimination Attorneys

Between fiscal 2020 and fiscal 2024, Cardinal Health, Inc. published documents describing four kinds of diversity, equity and inclusion practices: executive incentive pay tied to DE&I metrics, a candidate-pool rule requiring women and racially and ethnically diverse candidates, numeric race- and gender-specific representation goals running to 2030, and leadership programs described as being for underrepresented and minority employees. Cardinal Health's subsidiary Cardinal Health 200, LLC is a Defense Logistics Agency medical/surgical prime vendor, so the company operates under federal contracts that carry anti-discrimination certifications. Practices of these kinds were the basis of two False Claims Act settlements with the U.S. Department of Justice — IBM's $17 million in April 2026 and Deloitte's $21.5 million in August 2026, in which the whistleblower was paid $4.3 million. Both resolved allegations only.

Key facts

Did Cardinal Health tie executive pay to diversity targets?

The linkage starts in fiscal 2020. In its 2020 proxy statement, Cardinal Health, Inc. told shareholders:

"the Compensation Committee added new culture goals to our annual cash incentive and PSU grants during fiscal 2020" Cardinal Health, Inc., 2020 Proxy Statement (DEF 14A), filed September 2020, page 23

"The culture goals for the annual incentive program focused on performance management, change management and diversity and inclusion" Cardinal Health, Inc., 2020 Proxy Statement (DEF 14A), page 23

The same proxy states that the company "required unconscious bias training of every incentive eligible leader during fiscal 2020" and introduced a corporate culture goal in the fiscal 2020 annual cash incentive program for completion of that training.

The most specific description came in the company's own press release of August 23, 2021:

"Human Resources & Compensation Committee of the Cardinal Health Board of Directors recently approved expanding diversity, equity and inclusion (DE&I) metrics in the company's FY2022 annual incentive plan at the director level and above" Cardinal Health, "Cardinal Health Expands its DE&I Efforts with Comprehensive Talent Strategy," August 23, 2021

The same release states that the committee approved expanding DE&I metrics into the "performance proration of our long-term equity plan at the SVP level and above." Cardinal Health, Inc. repeated the substance of that decision to shareholders in two consecutive proxy statements, which describe:

"expanded diversity, equity, and inclusion (“DE&I”) metrics in the fiscal 2022 annual incentive plan and PSU program" Cardinal Health, Inc., 2021 Proxy Statement (DEF 14A), filed September 23, 2021; substantially repeated in the 2022 Proxy Statement (DEF 14A), filed September 28, 2022

The company's fiscal 2023 ESG report confirms the arrangement was still running years later: "Since fiscal 2022, DE&I learning objectives have been included in Cardinal Health's annual incentive plan."

What this meant in practice. A director-level or higher leader's cash bonus, and a senior vice president's equity payout, were measured in part against DE&I performance during the same years the company was publicly tracking progress toward numeric race- and gender-specific representation goals (below). When a manager's own compensation depends on a demographic scorecard, the demographics of the people that manager hires, promotes and retains stop being incidental to the decision.

Sources: 2020 DEF 14A · 2021 DEF 14A · 2022 DEF 14A · August 23, 2021 press release.

Did Cardinal Health require diverse candidate slates?

"the Governance and Sustainability Committee includes, and instructs any search firm to include, women and racially and ethnically diverse candidates in the initial pool from which candidates are selected" Cardinal Health, Inc., 2022 Proxy Statement (DEF 14A), corporate governance section; substantially repeated in the 2023 Proxy Statement

What this meant in practice. For board seats, the instruction operated on the composition of the pool itself: a search firm was directed to produce candidates of particular sexes and races before selection began. That is the same architecture the Justice Department described as "diverse interview slates" in the IBM settlement, applied at a different level of the organization. The document is a governance disclosure, not an employment policy, and this page does not assert that Cardinal Health applied the same rule to rank-and-file hiring.

By the 2025 proxy statement, this candidate-pool language no longer appears.

Source: 2022 DEF 14A · 2023 DEF 14A.

Did Cardinal Health set racial or gender representation goals?

"Between fiscal 2021 and fiscal 2030, see increased representation globally of women at the manager level and above, from 40% to 48%"

"Between fiscal 2021 and fiscal 2030, see increased representation in the U.S. of African American and Black employees at the manager level and above, from 5% to 11%"

"Between fiscal 2021 and fiscal 2030, see increased representation in the U.S. of Asian, Latino, Indigenous and all other ethnically diverse groups at the manager level and above, from 17% to 23%" Cardinal Health, Fiscal 2023 Environmental, Social and Governance Report

The 2021 and 2022 proxy statements state the same three targets to shareholders in the company's ESG section — "increase representation of women at the manager level and above to 48% (up from 40%)," "increase representation of African American and Black employees at the manager level and above to 11% (up from 5%)," and "increase representation of all other ethnically diverse groups at the manager level and above to 23% (up from 17%)."

The company also published its progress. As of the fiscal 2023 report, representation at the manager level and above stood at 41.5% women, 5.6% African American and Black employees, and 19.8% Asian, Latino, Indigenous and other ethnically diverse employees — each measured against its 2030 goal.

What this meant in practice. Doubling the share of Black and African American employees at manager level and above — from 5% to 11% — is not a description of an outcome the company hoped to observe; it is a number that has to be produced by decisions about specific promotions and specific hires. Read alongside the compensation section above, these are the goals the pay metrics measured leaders against. A goal by itself is not unlawful. What can matter legally is whether the goal changed who got the job.

Source: Cardinal Health Fiscal 2023 ESG Report · 2022 DEF 14A.

Did Cardinal Health run programs restricted by race or sex?

Describing a new suite of talent programs, the company's press release states that one program is:

"designed for underrepresented supply chain leaders not yet at the manager level" Cardinal Health, "Cardinal Health Expands its DE&I Efforts with Comprehensive Talent Strategy," August 23, 2021

and that the company would:

"expand the participation of minority women in the leadership programming of Women for Economic and Leadership Development" Cardinal Health, August 23, 2021 press release

What this meant in practice. Leadership development programs are a promotion pipeline. Where access to that pipeline is described by reference to race, ethnicity or sex, employees outside the described group may never learn a door existed. Whether that amounts to a legal problem depends on facts this page cannot resolve — whether eligibility was actually limited, and whether exclusion affected terms or conditions of employment. Those are exactly the facts an employee who applied, or who was told not to bother applying, would know.

Source: August 23, 2021 press release.

How Cardinal Health's DEI program changed, 2019–2026

This timeline is built from the company's own published documents. Where a document no longer states something an earlier one did, that change is described as it appears — the company has not, in the documents reviewed, published an explanation of when or why the goals and metrics were removed.

Why these practices matter legally

Title VII. 42 U.S.C. § 2000e-2 makes it unlawful to discriminate in hiring, promotion, compensation, or terms and conditions of employment because of race, color, religion, sex or national origin. The statute protects every employee, not only members of historically underrepresented groups.

Muldrow (2024). The Supreme Court held that a plaintiff challenging a discriminatory job transfer need show only some harm to a term or condition of employment, not a "significant" or "material" disadvantage. Exclusion from a leadership pipeline, a sponsorship program or a promotion track is the kind of injury that argument now reaches.

Ames (2025). In a unanimous decision, the Court struck down the "background circumstances" rule that some courts had used to require majority-group plaintiffs to make an extra showing before their claims could proceed. Read the opinion.

Section 1981. 42 U.S.C. § 1981 prohibits race discrimination in the making and enforcement of contracts, including employment. It requires no EEOC charge, has a four-year limitations period, and carries no statutory damages cap.

The False Claims Act route for federal contractors. On April 10, 2026, the U.S. Department of Justice announced that IBM would pay $17,077,043 to resolve allegations under the False Claims Act that it failed to comply with anti-discrimination requirements in its federal contracts — the first settlement under the DOJ's Civil Rights Fraud Initiative. The practices the government described included a "diversity modifier that tied bonus compensation to achieving demographic targets," "diverse interview slates," "race and sex demographic goals," and programs restricted by race or sex.

In August 2026 the government resolved a second, larger matter. Under a settlement agreement effective August 21, 2026, five Deloitte entities agreed to pay $21,500,000, of which $9,995,000 was restitution, covering conduct from January 1, 2017 through the settlement date. That agreement names the certification hook precisely — Title VII as incorporated into federal contracts and FAR clause 52.222-26 — and the government's theory reached not only what the company certified to its contracting agencies but what it "publicly represented" about its compliance. The agreement adds a second, independent theory: that the company "allocated costs to its federal government contracts relating to these practices and sought payment and reimbursement under its federal government contracts for such costs." The whistleblower was paid $4,300,000. Both settlements resolved allegations only, with no determination of liability, and Deloitte denies the conduct.

What a government settlement does not do. It releases the United States' claims and nothing else. The Deloitte agreement expressly reserves "any currently pending or future charges filed with the Equal Employment Opportunity Commission," and states that this "includes charges which may allege the same covered conduct described in this Agreement." It separately reserves "any liability of individuals," and administrative remedies including suspension and debarment. An individual's own claims are untouched by any of it.

The parallel fact for Cardinal Health, Inc. is its federal-contractor status: Cardinal Health 200, LLC holds Defense Logistics Agency Medical/Surgical Prime Vendor contracts supplying the military services and federal civilian agencies, and Cardinal Health entities hold Department of Veterans Affairs contracts. Whether that combination creates exposure for any particular company depends on the certifications it actually made and the practices actually in place — questions no public document answers by itself. For the complete framework — the four illegal DEI practice categories and when you can sue — see our guide, Is DEI Illegal? 4 Illegal DEI Practices & When You Can Sue.

Were you affected by these practices at Cardinal Health?

The documents above describe systems, not individual decisions. Whether anything unlawful happened to you turns on facts only you and your records hold. These situations are worth a conversation:

• You were passed over for a promotion to manager or above between roughly 2020 and 2025, in a business unit whose leaders were being measured against representation goals.
• You applied for a leadership development, sponsorship or cohort program and were told you were not eligible, or understood that it was not for you.
• You are a manager, HR professional or recruiter who saw how the DE&I metrics were scored, what the representation dashboards looked like, or how candidate pools were assembled.
• Your own bonus or equity award moved with a DE&I metric — you know what you were asked to deliver and how it was measured.
• You raised a concern about any of this and something happened to you afterward — a rating, a reassignment, a termination.

A federal settlement is not a substitute for your own claim: when the Justice Department resolved the Deloitte matter, it expressly preserved the EEOC's right to pursue charges alleging the very same conduct, and preserved individual liability. Nothing about that settlement compensated a single employee or applicant.

A consultation costs nothing and is confidential. If Cardinal Health, Inc. certified compliance with anti-discrimination requirements in its federal contracts while these practices operated, an insider with first-hand knowledge may also hold a False Claims Act whistleblower claim — those complaints are filed under seal, so the employer is not told while the government investigates, and a relator who succeeds can receive 15–30% of the government's recovery. Title VII and the False Claims Act both prohibit retaliation against people who assert these rights or report concerns.

If any of these fits, it costs nothing to find out where you stand — meet our DEI discrimination lawyers, or start below.

What could a claim against Cardinal Health be worth?

False Claims Act whistleblower rewards

Under 31 U.S.C. § 3730(d), a qui tam relator receives 15–25% of the government's recovery when the Department of Justice intervenes, and 25–30% when the relator proceeds without intervention. The Deloitte settlement supplies a paid benchmark rather than a projection: the relator received $4,300,000 — exactly 20% of a $21,500,000 recovery.

That settlement also shows why False Claims Act exposure outruns the money actually lost. Of the $21.5 million, $9,995,000 was restitution — roughly the government's single damages — so the resolution came to about 2.15 times the actual loss, because FCA recoveries are built on multiplied damages plus per-claim penalties. As a second illustration, arithmetic alone: an intervened case resolving at IBM's $17,077,043 would pay a relator roughly $2.6–$4.3 million. A contractor with a larger federal book or a longer conduct period could produce a materially larger number.

Damages in individual discrimination cases

Back pay and front pay are uncapped under Title VII. Compensatory and punitive damages are capped by employer size — $50,000 for employers with 15–100 employees, $100,000 for 101–200, $200,000 for 201–500, and $300,000 for employers with more than 500 employees, which is where a company of Cardinal Health's size sits. 42 U.S.C. § 1981 has no damages cap at all, which is why race claims are frequently pleaded under it. Many state statutes are also uncapped — Michigan's Elliott-Larsen Civil Rights Act among them. Prevailing plaintiffs generally recover attorney's fees on top.

For scale, prior results obtained by this firm include a $10.5 million race and age discrimination class action against Ford Motor Company, a $2 million disability harassment and retaliation result, a $1.6 million racially hostile work environment result, and a $1.1 million jury judgment against the Michigan State Police. Prior results do not guarantee a similar outcome.

Class action potential

One policy applied to many employees is what class actions are built on. Where a single compensation metric, a single set of representation goals, or a single program-eligibility rule reaches an entire population of employees, the common question that makes a class viable is already present. Historic employment-discrimination class recoveries give the scale: Coca-Cola settled for $192.5 million in 2000, Texaco for $176.1 million in 1996, and Novartis for $175 million in 2010.

Every case depends on its own facts; these figures show the range the law makes possible, not a prediction. The fastest way to learn what your situation supports is to start a confidential intake.

Sources